Literature DB >> 25701323

Oncogenic miR-23a in Pancreatic Ductal Adenocarcinogenesis Via Inhibiting APAF1.

Ning Liu1, Yuan-Yuan Sun, Xiao-Wen Zhang, Sheng Chen, Ye Wang, Zhao-Xiong Zhang, Shao-Wei Song, Guang-Bin Qiu, Wei-Neng Fu.   

Abstract

BACKGROUND: miR-23a, which participates in invasion of pancreatic ductal adenocarcinoma cells into the mesothelial barrier, is a critical regulator in many cancers. It, however, is still unknown whether miR-23a regulates pancreatic cell proliferation and apoptosis or not. AIMS: We sought to investigate the role of miR-23a in regulation of pancreatic cell proliferation and apoptosis.
METHODS: miRNA, mRNA, and protein expressions were determined by qRT-PCR and Western blot, respectively. Dual-luciferase reporter assay was used in detection for binding ability of miR-23a to APAF1. Ectopic miR-23a and APAF 1 were introduced to pancreatic cells, and their roles in proliferation and apoptosis were detected by MTT, colony formation, and apoptosis assays, respectively.
RESULTS: Up-regulation of miR-23a and down-regulation of APAF 1 were found in pancreatic ductal cancer, respectively. miR-23a significantly inhibited the luciferase activity by targeting APAF 1 3'UTR. Ectopic miR-23a significantly suppressed the APAF 1 gene expression in pancreatic cancer cells. Similar to siAPAF1, miR-23a significantly promoted pancreatic cancer cell proliferation and repressed apoptosis. Furthermore, miR-23a inhibitor and exogenous APAF 1 could recover the effects.
CONCLUSIONS: It is suggested that miR-23a, acting as an oncogenic regulator by directly targeting APAF 1 in pancreatic cancer, is a useful potential biomarker in diagnosis and treatment of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25701323     DOI: 10.1007/s10620-015-3588-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Up-regulated expression of miR-23a/b targeted the pro-apoptotic Fas in radiation-induced thymic lymphoma.

Authors:  Bailong Li; Mingjuan Sun; Fu Gao; Wen Liu; Yanyong Yang; Hu Liu; Ying Cheng; Cong Liu; Jianming Cai
Journal:  Cell Physiol Biochem       Date:  2013-12-13

2.  Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.

Authors:  Jason W Hoskins; Jinping Jia; Marta Flandez; Hemang Parikh; Wenming Xiao; Irene Collins; Mickey A Emmanuel; Abdisamad Ibrahim; John Powell; Lizhi Zhang; Nuria Malats; William R Bamlet; Gloria M Petersen; Francisco X Real; Laufey T Amundadottir
Journal:  Carcinogenesis       Date:  2014-09-18       Impact factor: 4.944

3.  Report of incidence and mortality in China cancer registries, 2009.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Guanglin Li; Lingyou Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

4.  Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia.

Authors:  Wei-Neng Fu; Francesco Bertoni; Stephen M Kelsey; Suzanne M McElwaine; Finbarr E Cotter; Adrian C Newland; Li Jia
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

5.  MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.

Authors:  Shuangli Mi; Jun Lu; Miao Sun; Zejuan Li; Hao Zhang; Mary Beth Neilly; Yungui Wang; Zhijian Qian; Jie Jin; Yanming Zhang; Stefan K Bohlander; Michelle M Le Beau; Richard A Larson; Todd R Golub; Janet D Rowley; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-04       Impact factor: 11.205

6.  Analysis of apoptosome dysregulation in pancreatic cancer and of its role in chemoresistance.

Authors:  Marco Corvaro; Claudia Fuoco; Martin Wagner; Francesco Cecconi
Journal:  Cancer Biol Ther       Date:  2007-02-25       Impact factor: 4.742

7.  MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer.

Authors:  H Listing; W A Mardin; S Wohlfromm; S T Mees; J Haier
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

8.  A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jennifer Permuth-Wey; Y Ann Chen; Kate Fisher; Susan McCarthy; Xiaotao Qu; Mark C Lloyd; Agnieszka Kasprzak; Michelle Fournier; Vonetta L Williams; Kavita M Ghia; Sean J Yoder; Laura Hall; Christina Georgeades; Funmilayo Olaoye; Kazim Husain; Gregory M Springett; Dung-Tsa Chen; Timothy Yeatman; Barbara Ann Centeno; Jason Klapman; Domenico Coppola; Mokenge Malafa
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

9.  miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells.

Authors:  Xue Liu; Jing Ru; Jian Zhang; Li-hua Zhu; Min Liu; Xin Li; Hua Tang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

10.  The involvement of miR-23a/APAF1 regulation axis in colorectal cancer.

Authors:  Fung Lin Yong; Chee Woon Wang; April Camilla Roslani; Chee Wei Law
Journal:  Int J Mol Sci       Date:  2014-07-02       Impact factor: 5.923

View more
  20 in total

Review 1.  Noncoding RNAs and pancreatic cancer.

Authors:  Juan-Fei Peng; Yan-Yan Zhuang; Feng-Ting Huang; Shi-Neng Zhang
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

2.  Mass spectrometry-based iTRAQ analysis of serum markers in patients with pancreatic cancer.

Authors:  Kai Jia; Xia Zhao; Xueyi Dang
Journal:  Oncol Lett       Date:  2020-03-29       Impact factor: 2.967

Review 3.  MicroRNA in pancreatic cancer.

Authors:  Keiichi Yonemori; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-02       Impact factor: 3.172

4.  High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.

Authors:  Xiao-Wen Zhang; Ning Liu; Sheng Chen; Ye Wang; Zhao-Xiong Zhang; Yuan-Yuan Sun; Guang-Bin Qiu; Wei-Neng Fu
Journal:  Diagn Pathol       Date:  2015-04-03       Impact factor: 2.644

5.  Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway.

Authors:  Yunpeng Sun; Chonglin Tao; Xiaming Huang; Han He; Hongqi Shi; Qiyu Zhang; Huanhuan Wu
Journal:  Onco Targets Ther       Date:  2016-05-12       Impact factor: 4.147

6.  Down-regulated miR-23a Contributes to the Metastasis of Cutaneous Melanoma by Promoting Autophagy.

Authors:  Weinan Guo; Huina Wang; Yuqi Yang; Sen Guo; Weigang Zhang; Yu Liu; Xiuli Yi; Jingjing Ma; Tao Zhao; Lin Liu; Zhe Jian; Ling Liu; Gang Wang; Tianwen Gao; Qiong Shi; Chunying Li
Journal:  Theranostics       Date:  2017-06-01       Impact factor: 11.556

Review 7.  Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.

Authors:  Mohammad Aslam Aslam Khan; Shafquat Azim; Haseeb Zubair; Arun Bhardwaj; Girijesh Kumar Patel; Moh'd Khushman; Seema Singh; Ajay Pratap Singh
Journal:  Int J Mol Sci       Date:  2017-04-06       Impact factor: 5.923

8.  Positive radionuclide imaging of miRNA expression using RILES and the human sodium iodide symporter as reporter gene is feasible and supports a protective role of miRNA-23a in response to muscular atrophy.

Authors:  Viorel Simion; Julien Sobilo; Rudy Clemoncon; Sharuja Natkunarajah; Safia Ezzine; Florence Abdallah; Stephanie Lerondel; Chantal Pichon; Patrick Baril
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

Review 9.  Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy.

Authors:  Marta Passadouro; Henrique Faneca
Journal:  Int J Mol Sci       Date:  2016-05-13       Impact factor: 5.923

10.  Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Tsutomu Kawaguchi; Hiroki Takeshita; Mahito Miyamae; Takuma Ohashi; Wataru Okajima; Taisuke Imamura; Jun Kiuchi; Tomohiro Arita; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Oncotarget       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.